ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Magnetic Resonance Imaging at Different Levels of Magnetic Intensity

This study has been suspended.

Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001619
  Purpose

Magnetic resonance imaging (MRI) is a diagnostic tool that creates high quality images of the human body without the use of X-ray (radiation). MRI uses different levels of magnetic fields to create images of the body and organs. Occasionally, researchers will give patients undergoing a MRI an injection of a substance called gadolinium. Gadolinium works by brightening areas of the magnetic resonance image, thereby improving the contrast.

In this study researchers will use magnetic resonance imaging and contrast substances, like gadolinium, on normal volunteers in order to evaluate different aspects of its performance. Information gathered from this study may be used to develop more specific research studies involving MRI.


Condition
Cardiovascular Disease
Healthy

Genetics Home Reference related topics:   ataxia-telangiectasia   

MedlinePlus related topics:   MRI Scans   

U.S. FDA Resources

Study Type:   Observational
Official Title:   Magnetic Resonance at 1.5 and 3 Tesla

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment:   600
Study Start Date:   November 1996

Detailed Description:

Technical evaluation of magnetic resonance imaging and spectroscopy will be performed on normal volunteers. These studies may involve the intravenous administration of commercially available MR contrast media. The results will be used to evaluate the performance of various pulse sequences, gradient coils, and rf coils on human subjects and will provide essential ground work for specific patient protocols.

  Eligibility
Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria
  • INCLUSION CRITERIA:

Any normal volunteer above the age of 18 who is capable of giving informed consent.

EXCLUSION CRITERIA:

A subject will be excluded if he/she has a contraindication to MR scanning such as:

Brain aneurysm clip;

Implanted neural stimulator;

Implanted cardiac pacemaker or defibrillator;

Cochlear implant;

Ocular foreign body (e.g. metal shavings);

Insulin pump.

Subjects will be excluded if it is deemed that they have a condition which would preclude their use for technical development (e.g. paralyzed hemidiaphragm, morbid obesity, claustrophobia, etc.) or present unnecessary risk (e.g. pregnancy, surgery of uncertain type, etc.).

Lactating women and subjects with hemoglobinopathies, asthma, or renal or hepatic disease will be excluded from studies involving the administration of contrast agents.

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001619

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike    
      Bethesda, Maryland, United States, 20892

Sponsors and Collaborators
  More Information

NIH Clinical Center Detailed Web Page  This link exits the ClinicalTrials.gov site
 

Publications:

Study ID Numbers:   970026, 97-H-0026
First Received:   November 3, 1999
Last Updated:   July 18, 2008
ClinicalTrials.gov Identifier:   NCT00001619
Health Authority:   United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Imaging  
Spectroscopy  
MRI  
Cardiovascular  
Technical Development  
Heart  
Safety
Toxicity
Gadolinium
Adverse Events
Normal Volunteer

Study placed in the following topic categories:
Ataxia-Telangiectasia
Healthy
Ataxia Telangiectasia

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on September 05, 2008




Links to all studies - primarily for crawlers